Last filing: Aug 20, 2026. Most recent sale before this period: Aug 28, 2024.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- Last sale before this period: Aug 28, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Regeneron Pharmaceuticals (REGN) | EVP Finance CFO | Mar 2, 2017 | Aug 20, 2026 |
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 18, 2026, Regeneron Pharmaceuticals: 6,283 shares acquired by exercising options; 4,599 shares withheld by the company for taxes. 1 filing: 1
- Dec 8, 2025, Regeneron Pharmaceuticals: 992 shares withheld by the company for taxes. 1 filing: 1
- Dec 5, 2025, Regeneron Pharmaceuticals: 3,027 shares awarded. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.